Marker Therapeutics
(NASDAQ:MRKR)
$4.1654
-0.1696[-3.91%]
At close: Mar 28
$4.1654
0[0.00%]
After Hours: 9:15AM EDT
Consensus Rating1
Neutral
Highest Price Target1
$1.00
Lowest Price Target1
$1.00
Consensus Price Target1
$1.00

Marker Therapeutics Stock (NASDAQ:MRKR), Analyst Ratings, Price Targets, Predictions

Marker Therapeutics Inc has a consensus price target of $1, established from looking at the 1 latest analyst ratings. The last 1 analyst ratings were released from Roth Capital on February 17, 2022. With an average price target of $1 between Roth Capital, there's an implied -75.99% downside for Marker Therapeutics Inc from these 1 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Feb
0
0
0
0
0
Jan
0
0
0
0
0
Dec 23
0
0
0
0
0
Nov 23
0
0
0
0
0
Oct 23
0
0
0
0
0
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Roth Capital

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Marker Therapeutics

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
02/17/2022MRKRBuy Now
Marker Therapeutics
$4.17-75.99%Roth Capital
Tony Butler
$30 → $10DowngradeBuy → NeutralGet Alert

FAQ

Q

What is the target price for Marker Therapeutics (MRKR)?

A

The latest price target for Marker Therapeutics (NASDAQ: MRKR) was reported by Roth Capital on February 17, 2022. The analyst firm set a price target for $1.00 expecting MRKR to fall to within 12 months (a possible -75.99% downside). 0 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Marker Therapeutics (MRKR)?

A

The latest analyst rating for Marker Therapeutics (NASDAQ: MRKR) was provided by Roth Capital, and Marker Therapeutics downgraded their neutral rating.

Q

When was the last upgrade for Marker Therapeutics (MRKR)?

A

There is no last upgrade for Marker Therapeutics.

Q

When was the last downgrade for Marker Therapeutics (MRKR)?

A

The last downgrade for Marker Therapeutics Inc happened on February 17, 2022 when Roth Capital changed their price target from $3 to $1 for Marker Therapeutics Inc.

Q

When is the next analyst rating going to be posted or updated for Marker Therapeutics (MRKR)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Marker Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Marker Therapeutics was filed on February 17, 2022 so you should expect the next rating to be made available sometime around February 17, 2023.

Q

Is the Analyst Rating Marker Therapeutics (MRKR) correct?

A

While ratings are subjective and will change, the latest Marker Therapeutics (MRKR) rating was a downgraded with a price target of $3.00 to $1.00. The current price Marker Therapeutics (MRKR) is trading at is $4.17, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch